Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2016

05.04.2016 | ORIGINAL ARTICLE

Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer

verfasst von: Suguru Yamada, Tsutomu Fujii, Akihiro Hirakawa, Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine which indicators, anatomical nodal metastasis (Japan Pancreas Society, JPS), number of positive lymph nodes (PLN), or lymph node ratio (LNR), is the best means of assessing lymph node involvement in pancreatic cancer.

Methods

This retrospective study analyzed 275 patients with pancreatic cancer treated at a single institution. Survival curves according to the JPS, PLN, or LNR were assessed by the Kaplan–Meier method. Prognostic value of each classification was explored by Cox regression analysis after adjustments for clinical factors.

Results

Multivariate analysis showed that, relative to n0 in the JPS, hazard ratios (HR) in n1, n2, and n3 were 1.72, 1.73, and 2.75, respectively, with no difference in survival between n1 and n2. Relative to PLN of 0, the HR in the PLN categories of 1∼2, 3, and >3 were 1.39, 1.65, and 3.03, respectively. Relative to LNR of 0, the HR in the categories of 0 < LNR ≤ 0.1, 0.1 < LNR ≤ 0.2, and LNR > 0.2 were 1.27, 2.00, and 5.58, respectively. An incremental increase in the HR was observed as the LNR category progressed, and differences between the survivals were distinct when stratified by the LNR.

Conclusions

The LNR was an accurate predictor of survival among three assessment strategies and could be proposed as a candidate for use as N categories, pending validation studies.
Literatur
1.
Zurück zum Zitat Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Brennan MF, Kattan MW, Klimstra D, Conlon K (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMedPubMedCentral Brennan MF, Kattan MW, Klimstra D, Conlon K (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594CrossRefPubMed Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594CrossRefPubMed
4.
Zurück zum Zitat Japanese Gastric Cancer A (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef Japanese Gastric Cancer A (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef
5.
Zurück zum Zitat Society JP (2011) Classification of pancreatic carcinoma, Third English Editionth edn. Kanehara & Co., Ltd., Tokyo Society JP (2011) Classification of pancreatic carcinoma, Third English Editionth edn. Kanehara & Co., Ltd., Tokyo
6.
Zurück zum Zitat Smith DD, Schwarz RR, Schwarz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23:7114–7124CrossRefPubMed Smith DD, Schwarz RR, Schwarz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23:7114–7124CrossRefPubMed
7.
Zurück zum Zitat Ludwig MS, Goodman M, Miller DL, Johnstone PA (2005) Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128:1545–1550CrossRefPubMed Ludwig MS, Goodman M, Miller DL, Johnstone PA (2005) Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128:1545–1550CrossRefPubMed
8.
Zurück zum Zitat International Union Against Cancer (2009) TNM classification of malignant tumors, Vol 7th edn. Wiley-Blackwell, New York International Union Against Cancer (2009) TNM classification of malignant tumors, Vol 7th edn. Wiley-Blackwell, New York
9.
Zurück zum Zitat Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784CrossRefPubMed Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784CrossRefPubMed
10.
Zurück zum Zitat Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D et al (2007) The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 245:543–552CrossRefPubMedPubMedCentral Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D et al (2007) The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 245:543–552CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919CrossRefPubMed Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919CrossRefPubMed
12.
Zurück zum Zitat Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608CrossRefPubMed Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608CrossRefPubMed
13.
Zurück zum Zitat Petrelli F, Borgonovo K, Barni S (2011) The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature. Eur J Surg Oncol 37:836–847CrossRefPubMed Petrelli F, Borgonovo K, Barni S (2011) The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature. Eur J Surg Oncol 37:836–847CrossRefPubMed
14.
Zurück zum Zitat Hida J, Okuno K, Yasutomi M, Yoshifuji T, Matsuzaki T, Uchida T et al (2005) Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg 201:217–222CrossRefPubMed Hida J, Okuno K, Yasutomi M, Yoshifuji T, Matsuzaki T, Uchida T et al (2005) Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg 201:217–222CrossRefPubMed
15.
Zurück zum Zitat Nakao A, Takagi H (1993) Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 40:426–429PubMed Nakao A, Takagi H (1993) Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 40:426–429PubMed
16.
Zurück zum Zitat Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H et al (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg 30:976–982CrossRefPubMed Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H et al (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg 30:976–982CrossRefPubMed
17.
Zurück zum Zitat Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A et al (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196–204CrossRefPubMed Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A et al (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196–204CrossRefPubMed
18.
Zurück zum Zitat Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, Capussotti L (2009) Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol 16:3323–3332CrossRefPubMed Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, Capussotti L (2009) Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol 16:3323–3332CrossRefPubMed
19.
Zurück zum Zitat Pomianowska E, Westgaard A, Mathisen O, Clausen OP, Gladhaug IP (2013) Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas. Ann Surg Oncol 20:233–241CrossRefPubMed Pomianowska E, Westgaard A, Mathisen O, Clausen OP, Gladhaug IP (2013) Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas. Ann Surg Oncol 20:233–241CrossRefPubMed
20.
Zurück zum Zitat Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240PubMed Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240PubMed
21.
Zurück zum Zitat Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed
22.
Zurück zum Zitat Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165–174CrossRefPubMed Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165–174CrossRefPubMed
23.
Zurück zum Zitat Nakao A, Harada A, Nonami T, Kaneko T, Murakami H, Inoue S et al (1995) Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg 82:399–402CrossRefPubMed Nakao A, Harada A, Nonami T, Kaneko T, Murakami H, Inoue S et al (1995) Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg 82:399–402CrossRefPubMed
24.
Zurück zum Zitat Nakao A, Harada A, Nonami T, Kaneko T, Nomoto S, Koyama H et al (1997) Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg 84:1090–1092CrossRefPubMed Nakao A, Harada A, Nonami T, Kaneko T, Nomoto S, Koyama H et al (1997) Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg 84:1090–1092CrossRefPubMed
25.
Zurück zum Zitat Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S et al (2009) Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas 38:e13–e17CrossRefPubMed Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S et al (2009) Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas 38:e13–e17CrossRefPubMed
26.
Zurück zum Zitat Schwarz RE, Smith DD (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13:1189–1200CrossRefPubMed Schwarz RE, Smith DD (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13:1189–1200CrossRefPubMed
27.
Zurück zum Zitat House MG, Gonen M, Jarnagin WR, D’Angelica M, DeMatteo RP, Fong Y et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed House MG, Gonen M, Jarnagin WR, D’Angelica M, DeMatteo RP, Fong Y et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed
28.
Zurück zum Zitat Malleo G, Maggino L, Capelli P, Gulino F, Segattini S, Scarpa A et al (2015) Reappraisal of nodal staging and study of lymph node station involvement in pancreaticoduodenectomy with the standard International Study Group of Pancreatic Surgery definition of lymphadenectomy for cancer. J Am Coll Surg 221:367–379CrossRefPubMed Malleo G, Maggino L, Capelli P, Gulino F, Segattini S, Scarpa A et al (2015) Reappraisal of nodal staging and study of lymph node station involvement in pancreaticoduodenectomy with the standard International Study Group of Pancreatic Surgery definition of lymphadenectomy for cancer. J Am Coll Surg 221:367–379CrossRefPubMed
29.
Zurück zum Zitat Strobel O, Hinz U, Gluth A, Hank T, Hackert T et al (2015) Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg 261:961–969CrossRefPubMed Strobel O, Hinz U, Gluth A, Hank T, Hackert T et al (2015) Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg 261:961–969CrossRefPubMed
30.
Zurück zum Zitat Basturk O, Saka B, Balci S, Postlewait LM, Knight J, Goodman M et al (2015) Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM Staging. Ann Surg Oncol 22:1187–1195CrossRef Basturk O, Saka B, Balci S, Postlewait LM, Knight J, Goodman M et al (2015) Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM Staging. Ann Surg Oncol 22:1187–1195CrossRef
31.
Zurück zum Zitat Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371CrossRefPubMed Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371CrossRefPubMed
32.
Zurück zum Zitat Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB (2011) Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg 213:45–52CrossRefPubMed Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB (2011) Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. J Am Coll Surg 213:45–52CrossRefPubMed
33.
Zurück zum Zitat Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M et al (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 283:14665–14673CrossRefPubMedPubMedCentral Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M et al (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 283:14665–14673CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517CrossRefPubMedPubMedCentral Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366CrossRefPubMedPubMedCentral Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y et al (2012) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230–241CrossRefPubMed Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y et al (2012) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230–241CrossRefPubMed
37.
Zurück zum Zitat Adsay NV, Basturk O, Altinel D, Khanani F, Coban I, Weaver DW et al (2009) The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 22:107–112CrossRefPubMed Adsay NV, Basturk O, Altinel D, Khanani F, Coban I, Weaver DW et al (2009) The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 22:107–112CrossRefPubMed
38.
Zurück zum Zitat Edge SB BD, Compton CC, Fritz AG, Green FL, Trotti A (eds) (2010) AJCC cancer staging manual, Vol 7th edn. Springer, Chicago Edge SB BD, Compton CC, Fritz AG, Green FL, Trotti A (eds) (2010) AJCC cancer staging manual, Vol 7th edn. Springer, Chicago
39.
Zurück zum Zitat Valsangkar NP, Bush DM, Michaelson JS, Ferrone CR, Wargo JA, Lillemoe KD et al (2013) N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg 17:257–266CrossRefPubMed Valsangkar NP, Bush DM, Michaelson JS, Ferrone CR, Wargo JA, Lillemoe KD et al (2013) N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg 17:257–266CrossRefPubMed
40.
Zurück zum Zitat Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R et al (2012) Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg 16:920–926CrossRefPubMed Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R et al (2012) Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg 16:920–926CrossRefPubMed
Metadaten
Titel
Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer
verfasst von
Suguru Yamada
Tsutomu Fujii
Akihiro Hirakawa
Mitsuro Kanda
Hiroyuki Sugimoto
Yasuhiro Kodera
Publikationsdatum
05.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2016
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1412-5

Weitere Artikel der Ausgabe 8/2016

Langenbeck's Archives of Surgery 8/2016 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.